search
Back to results

Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury

Primary Purpose

Acute Lung Injury

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
noninvasive positive pressure ventilation
oxygen therapy
Sponsored by
Beijing Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Lung Injury focused on measuring ALI;noninvasive positive pressure ventilation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. acute onset;
  2. a clinical presentation of respiratory distress;
  3. arterial oxygen tension/inspired oxygen fraction (PaO2/FIO2) < 300 mmHg but > 200 mmHg while breathing oxygen delivered by a conventional Venturi device at a maximum concentration (50%);
  4. presence of bilateral pulmonary infiltrates on posteroanterior chest radiograph;
  5. no evidence of left heart failure as assessed by echocardiography and/or a pulmonary artery wedge pressure of <18 mm Hg.
  6. the cause of ALI is consider to be intro-pulmonary.

Exclusion Criteria:

  1. age <18 yrs;
  2. Glasgow Coma Scale < 11;
  3. airway or facial injury;
  4. pneumothorax or pneumomediastinum;
  5. unable to spontaneously clear secretions from the airways;
  6. cardiogenic shock or severe hemodynamic instability (systolic blood pressure <90 mmHg associated with decreased urinary output (<20 mL.h-1) despite fluid repletion and use of vasoactive agents) of other causes;
  7. severe ventricular arrhythmia or unstable myocardial ischemia;
  8. severe organ dysfunction (Sequential Organ Failure Assessment score > 3);
  9. end-stage patients who were expected to survive < 6 months;
  10. severe abdominal distension;
  11. refusal to receive NPPV;
  12. the cause of ALI is consider to be extrapulmonary;
  13. unable to cooperate with NPPV application;
  14. active upper gastrointestinal bleeding.

Sites / Locations

  • Beijing Hospital of the Ministry of Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

NPPV

Control

Arm Description

Outcomes

Primary Outcome Measures

numbers of patients who met the intubation criteria
the numbers of patients who are actually intubated

Secondary Outcome Measures

inhospital mortalities
intensive care unit mortalities

Full Information

First Posted
April 18, 2012
Last Updated
November 20, 2018
Sponsor
Beijing Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01581229
Brief Title
Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beijing Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To assess the safety and efficacy of noninvasive positive pressure ventilation for patients with intro-pulmonary pulmonary acute lung injury and compare this with high-concentration oxygen therapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Lung Injury
Keywords
ALI;noninvasive positive pressure ventilation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
204 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NPPV
Arm Type
Experimental
Arm Title
Control
Arm Type
Active Comparator
Intervention Type
Procedure
Intervention Name(s)
noninvasive positive pressure ventilation
Intervention Description
Patients in the NPPV group are ventilated using the CPAP or bilevel positive airways pressure S/T mode.
Intervention Type
Procedure
Intervention Name(s)
oxygen therapy
Intervention Description
In the control group, Venturi masks are used to maintain SpO2 at 92% to 96% by adjusting the oxygen flow rates.
Primary Outcome Measure Information:
Title
numbers of patients who met the intubation criteria
Time Frame
1 year
Title
the numbers of patients who are actually intubated
Time Frame
1 year
Secondary Outcome Measure Information:
Title
inhospital mortalities
Time Frame
1 year
Title
intensive care unit mortalities
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: acute onset; a clinical presentation of respiratory distress; arterial oxygen tension/inspired oxygen fraction (PaO2/FIO2) < 300 mmHg but > 200 mmHg while breathing oxygen delivered by a conventional Venturi device at a maximum concentration (50%); presence of bilateral pulmonary infiltrates on posteroanterior chest radiograph; no evidence of left heart failure as assessed by echocardiography and/or a pulmonary artery wedge pressure of <18 mm Hg. the cause of ALI is consider to be intro-pulmonary. Exclusion Criteria: age <18 yrs; Glasgow Coma Scale < 11; airway or facial injury; pneumothorax or pneumomediastinum; unable to spontaneously clear secretions from the airways; cardiogenic shock or severe hemodynamic instability (systolic blood pressure <90 mmHg associated with decreased urinary output (<20 mL.h-1) despite fluid repletion and use of vasoactive agents) of other causes; severe ventricular arrhythmia or unstable myocardial ischemia; severe organ dysfunction (Sequential Organ Failure Assessment score > 3); end-stage patients who were expected to survive < 6 months; severe abdominal distension; refusal to receive NPPV; the cause of ALI is consider to be extrapulmonary; unable to cooperate with NPPV application; active upper gastrointestinal bleeding.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chen Wang, MD, PHD
Organizational Affiliation
Beijing Hospital of the Ministry of Health; Beijing Institute of Respiratory Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beijing Hospital of the Ministry of Health
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100020
Country
China

12. IPD Sharing Statement

Citations:
PubMed Identifier
31484582
Citation
He H, Sun B, Liang L, Li Y, Wang H, Wei L, Li G, Guo S, Duan J, Li Y, Zhou Y, Chen Y, Li H, Yang J, Xu X, Song L, Chen J, Bao Y, Chen F, Wang P, Ji L, Zhang Y, Ding Y, Chen L, Wang Y, Yang L, Yang T, Weng H, Li H, Wang D, Tong J, Sun Y, Li R, Jin F, Li C, He B, Sun L, Wang C, Hu M, Yang X, Luo Q, Zhang J, Tan H, Wang C; ENIVA Study Group. A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome. Crit Care. 2019 Sep 4;23(1):300. doi: 10.1186/s13054-019-2575-6.
Results Reference
derived

Learn more about this trial

Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury

We'll reach out to this number within 24 hrs